| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |